155 related articles for article (PubMed ID: 12750027)
1. Impact of the aryl substituent kind and distance from pyrimido[2,1-f]purindiones on the adenosine receptor selectivity and antagonistic properties.
Drabczyńska A; Schumacher B; Müller CE; Karolak-Wojciechowska J; Michalak B; Pekala E; Kieć-Kononowicz K
Eur J Med Chem; 2003 Apr; 38(4):397-402. PubMed ID: 12750027
[TBL] [Abstract][Full Text] [Related]
2. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.
Kim YC; Ji X; Melman N; Linden J; Jacobson KA
J Med Chem; 2000 Mar; 43(6):1165-72. PubMed ID: 10737749
[TBL] [Abstract][Full Text] [Related]
3. N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors.
Drabczyńska A; Müller CE; Karolak-Wojciechowska J; Schumacher B; Schiedel A; Yuzlenko O; Kieć-Kononowicz K
Bioorg Med Chem; 2007 Jul; 15(14):5003-17. PubMed ID: 17499511
[TBL] [Abstract][Full Text] [Related]
4. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists.
Strappaghetti G; Corsano S; Barbaro R; Giannaccini G; Betti L
Bioorg Med Chem; 2001 Mar; 9(3):575-83. PubMed ID: 11310591
[TBL] [Abstract][Full Text] [Related]
6. 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.
Koch P; Akkari R; Brunschweiger A; Borrmann T; Schlenk M; Küppers P; Köse M; Radjainia H; Hockemeyer J; Drabczyńska A; Kieć-Kononowicz K; Müller CE
Bioorg Med Chem; 2013 Dec; 21(23):7435-52. PubMed ID: 24139167
[TBL] [Abstract][Full Text] [Related]
7. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands.
Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K
Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of tricyclic aryloimidazo-, pyrimido-, and diazepinopurinediones.
Drabczyńska A; Müller CE; Lacher SK; Schumacher B; Karolak-Wojciechowska J; Nasal A; Kawczak P; Yuzlenko O; Pekala E; Kieć-Kononowicz K
Bioorg Med Chem; 2006 Nov; 14(21):7258-81. PubMed ID: 16844379
[TBL] [Abstract][Full Text] [Related]
9. Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists.
Müller CE; Thorand M; Qurishi R; Diekmann M; Jacobson KA; Padgett WL; Daly JW
J Med Chem; 2002 Aug; 45(16):3440-50. PubMed ID: 12139454
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in the field of A2A and A3 adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Bovero A; Avitabile B; Preti D; Fruttarolo F; Romagnoli R; Varani K; Borea PA
Eur J Med Chem; 2003 Apr; 38(4):367-82. PubMed ID: 12750024
[TBL] [Abstract][Full Text] [Related]
11. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G
J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
13. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
14. 7-Deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists.
Hess S; Müller CE; Frobenius W; Reith U; Klotz KN; Eger K
J Med Chem; 2000 Nov; 43(24):4636-46. PubMed ID: 11101355
[TBL] [Abstract][Full Text] [Related]
15. Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptor.
Beauglehole AR; Baker SP; Scammells PJ
J Med Chem; 2000 Dec; 43(26):4973-80. PubMed ID: 11150167
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
[TBL] [Abstract][Full Text] [Related]
17. Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors.
Jacobson KA; Shi D; Gallo-Rodriguez C; Manning M; Müller C; Daly JW; Neumeyer JL; Kiriasis L; Pfleiderer W
J Med Chem; 1993 Sep; 36(18):2639-44. PubMed ID: 8410976
[TBL] [Abstract][Full Text] [Related]
18. 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors.
Brunschweiger A; Koch P; Schlenk M; Rafehi M; Radjainia H; Küppers P; Hinz S; Pineda F; Wiese M; Hockemeyer J; Heer J; Denonne F; Müller CE
Bioorg Med Chem; 2016 Nov; 24(21):5462-5480. PubMed ID: 27658798
[TBL] [Abstract][Full Text] [Related]
19. 8-(Sulfostyryl)xanthines: water-soluble A2A-selective adenosine receptor antagonists.
Müller CE; Sandoval-Ramírez J; Schobert U; Geis U; Frobenius W; Klotz KN
Bioorg Med Chem; 1998 Jun; 6(6):707-19. PubMed ID: 9681137
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists.
Rodríguez-Borges JE; García-Mera X; Balo MC; Brea J; Caamaño O; Fernández F; López C; Loza MI; Nieto MI
Bioorg Med Chem; 2010 Mar; 18(5):2001-9. PubMed ID: 20137957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
